News
Ernst & Young names Stern Entrepreneur of Year in Health Sciences for making Talecris "world-class business"
PR Newswire
PALM SPRINGS, CA — Lawrence D. Stern, Chairman and CEO, Talecris Biotherapeutics, on Sunday was named the Ernst & Young Entrepreneur Of The Year 2010 national winner in the Health Sciences category.
Ernest & Young honored Stern for growing Talecris into one of the leading plasma therapeutics companies in the world. The award recognizes leaders and visionaries who demonstrate innovation, financial success and personal commitment as they create and build world-class businesses.
Lawrence Stern of Talecris
“On behalf of the Alpha-1 Foundation Board, congratulations to Larry Stern for this incredible recognition,” said John Walsh, Foundation President & CEO. “We have witnessed firsthand his dedication to enhanced patient care. He understands the importance of having individuals with Alpha-1 participate in their health management, the core function of AlphaNet.”
Walsh said the honor “acknowledges that excellence in personal health management goes hand in hand with success in the health science business. Larry exemplifies the dedication and continuous commitment to the Alpha-1 community that is embedded in Talecris’ culture. He has led by example. We are truly grateful for his commitment to enhanced therapies for Alpha-1.”
Awards were given in nine additional categories. Winners were selected by an independent panel of judges from approximately 300 regional award recipients.
Bryan Pearce of Ernst & Young LLP, said, “The health sciences industry is inherently risky; speed and accuracy determine a company’s success or failure. Lawrence has carved out a leadership role for Talecris Biotheraputics by following a number of critical entrepreneurial strategies: determining the company’s capacity and appetite for risk, making substantial investments in research and development, and constantly increasing the speed of the company’s product to market.”
